Illumina Inc. (ILMN) News

Illumina Inc. (ILMN): $210.00

1.30 (+0.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ILMN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Filter ILMN News Items

ILMN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ILMN News Highlights

  • For ILMN, its 30 day story count is now at 44.
  • Over the past 24 days, the trend for ILMN's stories per day has been choppy and unclear. It has oscillated between 1 and 15.
  • EU, MA and PAY are the most mentioned tickers in articles about ILMN.

Latest ILMN News From Around the Web

Below are the latest news stories about ILLUMINA INC that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

How Organizations Around the World Are Closing the Cancer Care Gap

NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / Illumina Originally published on Illumina News Center According to the World Health Organization, half the world's population does not have access to essential health services. At a time when advances ...

Yahoo | February 3, 2023

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 2, 2023

Illumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Year

Illumina has been included in the 2023 Bloomberg Gender-Equality Index for the fifth consecutive year.

Yahoo | February 1, 2023

Top 25 Smartest Companies To Buy According To Hedge Funds

In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds. For more companies, head on over to Top 5 Smartest Companies To Buy According To Hedge Funds. Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless […]

Yahoo | February 1, 2023

Illumina Makes Its Interim CFO Permanent

Joydeep Goswami, Illumina’s interim finance chief since July, will take over the role on a permanent basis.

Yahoo | February 1, 2023

Illumina Appoints Joydeep Goswami Chief Financial Officer

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina's Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company's financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. He will also con

Yahoo | February 1, 2023

Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders

NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / Illumina Originally published on Illumina News Center The Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK's genomics events calendar. More than 4000 ...

Yahoo | January 31, 2023

Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for

Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | January 31, 2023

Has Illumina taken the wrong path in its Grail quest?

DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators

Yahoo | January 29, 2023

Health-Care Stocks Have Outperformed; Here Are a Few Undervalued.

The S&P 500 Healthcare index gained 4.8% during the past 12 months, versus a 6% dip for the S&P 500 as a whole.

Yahoo | January 27, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5574 seconds.